|
|
||||||||

Departments of
*
Neurology and
Microbiology and Molecular Immunology, University of Southern California School of Medicine, Los Angeles, CA 90033
CD8+ effectors are critical components of type 1
responses against viral infections as well as for antiviral vaccines.
IL-4 plays a clear role as an inhibitor of CD4+ Th1 cells;
however, its role in CD8+ T cell regulation appears to be
more complex. Thus, IL-4 may augment CD8+ T cell growth,
but also limit effector function. Moreover, abundant IL-4 is inhibitory
for viral clearance, but the lack of IL-4 appears not to affect
CTL-mediated immunity. This report investigates these disparate roles
of IL-4 in CD8+ T lymphocyte regulation by comparing T cell
responses specific for a single HIV-IIIIB gp120-derived
epitope in BALB/c mice deficient in IL-4 to those in wild-type
controls. CTL activation was monitored during the acute and memory
phases following immunization with recombinant vaccinia virus. Similar
frequencies of gp120-specific CTL precursors in splenocytes from both
groups indicated that IL-4 plays no significant role in either CTL
priming or the establishment of memory. However, cytolytic activity in
cultures derived from IL-4-deficient mice developed earlier and was
strikingly enhanced following in vitro restimulation, an effect
exhibited by both primary and memory T cells. Secretion of IL-2 and
IFN-
by CD8+ T cells from IL-4-deficient mice was also
elevated, reflecting their enhanced activation. Thus, IL-4 appears to
limit the activation, expansion, and differentiation of
CD8+ T cells with high cytolytic
potential.
This article has been cited by other articles:
![]() |
C. Riou, A. R Dumont, B. Yassine-Diab, E. K Haddad, and R.-P. Sekaly IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells Int. Immunol., June 1, 2006; 18(6): 827 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kienzle, S. Olver, K. Buttigieg, P. Groves, M. L. Janas, A. Baz, and A. Kelso Progressive Differentiation and Commitment of CD8+ T Cells to a Poorly Cytolytic CD8low Phenotype in the Presence of IL-4 J. Immunol., February 15, 2005; 174(4): 2021 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Kim, T. M. Stringfield, Y. Chen, and H. E. Broxmeyer Modulation of cord blood CD8+ T-cell effector differentiation by TGF-{beta}1 and 4-1BB costimulation Blood, January 1, 2005; 105(1): 274 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Roberts, J. Yang, and F. Ronchese IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo Int. Immunol., October 1, 2004; 16(10): 1451 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chang, J.-H. Cho, S.-W. Lee, S.-Y. Choi, S.-J. Ha, and Y.-C. Sung IL-12 Priming during In Vitro Antigenic Stimulation Changes Properties of CD8 T Cells and Increases Generation of Effector and Memory Cells J. Immunol., March 1, 2004; 172(5): 2818 - 2826. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kienzle, K. Buttigieg, P. Groves, T. Kawula, and A. Kelso A Clonal Culture System Demonstrates That IL-4 Induces a Subpopulation of Noncytolytic T Cells with Low CD8, Perforin, and Granzyme Expression J. Immunol., February 15, 2002; 168(4): 1672 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. F. Bathe, N. Dalyot-Herman, and T. R. Malek IL-2 During In Vitro Priming Promotes Subsequent Engraftment and Successful Adoptive Tumor Immunotherapy by Persistent Memory Phenotypic CD8+ T Cells J. Immunol., October 15, 2001; 167(8): 4511 - 4517. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mullbacher and M. Lobigs Creation of Killer Poxvirus Could Have Been Predicted J. Virol., September 15, 2001; 75(18): 8353 - 8355. [Full Text] [PDF] |
||||
![]() |
S. Aung and B. S. Graham IL-4 Diminishes Perforin-Mediated and Increases Fas Ligand-Mediated Cytotoxicity In Vivo J. Immunol., April 1, 2000; 164(7): 3487 - 3493. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aung, Y.-W. Tang, and B. S. Graham Interleukin-4 Diminishes CD8+ Respiratory Syncytial Virus-Specific Cytotoxic T-Lymphocyte Activity In Vivo J. Virol., November 1, 1999; 73(11): 8944 - 8949. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fallarino and T. F. Gajewski Cutting Edge: Differentiation of Antitumor CTL In Vivo Requires Host Expression of Stat1 J. Immunol., October 15, 1999; 163(8): 4109 - 4113. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-R. Huang, F.-L. Chen, Y.-T. Chen, Y.-M. Lin, and J. T. Kung Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation PNAS, March 28, 2000; 97(7): 3406 - 3411. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |